| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-5223(03)01025-0 |
| P698 | PubMed publication ID | 14666038 |
| P50 | author | Eugene H Blackstone | Q96650503 |
| P2093 | author name string | Lisa A Rybicki | |
| Malcolm M DeCamp | |||
| Thomas W Rice | |||
| Sudish C Murthy | |||
| David J Adelstein | |||
| Mark A Chidel | |||
| P2860 | cites work | Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial | Q73624732 |
| Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer | Q77738544 | ||
| Surgical treatment of esophageal cancer--the advent of the era of individualization | Q78551352 | ||
| Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 | ||
| Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma | Q32033905 | ||
| Preoperative radiotherapy in esophageal carcinoma: a meta-analysis using individual patient data (Oesophageal Cancer Collaborative Group). | Q32060428 | ||
| A randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group Study. | Q50939021 | ||
| Comparing apples and oranges. | Q52048734 | ||
| Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. | Q53395748 | ||
| The central role of the propensity score in observational studies for causal effects | Q56882400 | ||
| Superficial adenocarcinoma of the esophagus | Q61826594 | ||
| Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01 | Q68125681 | ||
| Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma | Q68702101 | ||
| A comparison of multimodal therapy and surgery for esophageal adenocarcinoma | Q71164736 | ||
| Integration of surgery in multimodality therapy for esophageal cancer | Q73039419 | ||
| Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma | Q73446130 | ||
| Chemoradiotherapy Followed by Surgery Compared with Surgery Alone in Squamous-Cell Cancer of the Esophagus | Q73502951 | ||
| N1 esophageal carcinoma: the importance of staging and downstaging | Q73592075 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chemoradiotherapy | Q5090613 |
| P304 | page(s) | 1590-1596 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | The Journal of Thoracic and Cardiovascular Surgery | Q2795598 |
| P1476 | title | Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma | |
| P478 | volume | 126 |
| Q89763378 | A phase-II/III randomized controlled trial of adjuvant radiotherapy or concurrent chemoradiotherapy after surgery versus surgery alone in patients with stage-IIB/III esophageal squamous cell carcinoma |
| Q55334175 | A retrospective study of pattern of recurrence after radical surgery for thoracic esophageal carcinoma with or without postoperative radiotherapy. |
| Q34567560 | A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. |
| Q41439893 | Adjuvant Therapeutic Modalities Following Three-field Lymph Node Dissection for Stage II/III Esophageal Squamous Cell Carcinoma |
| Q36556865 | Adjuvant Therapy for Positive Nodes After Induction Therapy and Resection of Esophageal Cancer |
| Q30537735 | Adjuvant concurrent chemoradiation using intensity-modulated radiotherapy and simultaneous integrated boost for resected high-risk adenocarcinoma of the distal esophagus and gastro-esophageal junction |
| Q37854733 | Chemoradiation therapy in the management of gastrointestinal malignancies |
| Q35667631 | Clinical T2N0M0 carcinoma of thoracic esophagus |
| Q40257625 | Compound Radix Sophorae Flavescentis exerts antitumor effects by inhibiting the proliferation and inducing the apoptosis of esophageal carcinoma TE-8 cells |
| Q42342010 | Do we have enough evidence for adjuvant postoperative chemoradiation in esophageal cancer? |
| Q44575322 | Effect of the number of lymph nodes sampled on postoperative survival of lymph node-negative esophageal cancer |
| Q36051703 | Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma |
| Q36076031 | Epidermal growth factor receptor expression in esophageal adenocarcinoma: relationship with tumor stage and survival after esophagectomy |
| Q90484036 | Esophageal squamous cell carcinoma and prognosis in Taiwan |
| Q36213998 | Esophagectomy for locally advanced esophageal cancer, followed by chemoradiotherapy and adjuvant chemotherapy |
| Q37207101 | Impact of Treatment Modalities on Survival of Patients With Locoregional Esophageal Squamous-Cell Carcinoma in Taiwan. |
| Q33764809 | Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma |
| Q80514902 | Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma |
| Q37799418 | Management of Esophageal Cancer |
| Q48295274 | Meta-analysis of survival benefit with postoperative chemoradiotherapy in patients of lymph node positive esophageal carcinoma |
| Q39285940 | Neoadjuvant versus adjuvant chemoradiation for stage II-III esophageal squamous cell carcinoma: a single institution experience |
| Q36093882 | Nomogram and recursive partitioning analysis to predict overall survival in patients with stage IIB-III thoracic esophageal squamous cell carcinoma after esophagectomy |
| Q58755645 | Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy |
| Q33599231 | Patterns of failure after radical surgery among patients with thoracic esophageal squamous cell carcinoma: implications for the clinical target volume design of postoperative radiotherapy |
| Q40470309 | Patterns of recurrence after oesophagectomy and postoperative chemoradiotherapy versus surgery alone for oesophageal squamous cell carcinoma. |
| Q37455214 | Postoperative chemoradiotherapy improves survival in patients with stage II-III esophageal squamous cell carcinoma: An analysis of clinical outcomes |
| Q24202240 | Postoperative chemotherapy or radiotherapy for esophageal cancer |
| Q37292447 | Postoperative extended-volume external-beam radiation therapy in high-risk esophageal cancer patients: a prospective experience |
| Q26741018 | Postoperative radiation in esophageal squamous cell carcinoma and target volume delineation |
| Q51577934 | Problematic esophageal stricture: an emerging indication for self-expandable silicone stents. |
| Q42743222 | Quality of life in patients with esophageal cancer receiving definitive chemoradiotherapy or esophagectomy |
| Q38027516 | Radiation therapy in the postoperative management of esophageal cancer |
| Q92680395 | Radical esophagectomy for stage II and III thoracic esophageal squamous cell carcinoma followed by adjuvant radiotherapy with or without chemotherapy: Which is more beneficial? |
| Q50300226 | Role of Postoperative Concurrent Chemoradiotherapy for Esophageal Carcinoma: A meta-analysis of 2165 Patients. |
| Q37245924 | Role of postoperative radiotherapy for microscopic margin involvement in the squamous cell carcinoma of esophagus |
| Q47440080 | Role of the modern radiotherapy in the postoperative setting for esophageal cancer |
| Q90630944 | The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma |
| Q35857902 | The Prognostic Impact of Preoperative and Postoperative Chemoradiation in Clinical Stage II and III Esophageal Squamous Cell Carcinomas: A Population Based Study in Taiwan |
| Q86498776 | Therapeutic efficacy evaluation of postoperative adjuvant radiotherapy in mid-thoracic esophageal carcinoma patients underwent Ivor Lewis esophagectomy with two-field lymphadenectomy |
| Q36485831 | Updates on esophageal and gastric cancers |
| Q41453138 | What are the factors that predict outcome at relapse after previous esophagectomy and adjuvant therapy in high-risk esophageal cancer? |
Search more.